ARCHIVES

NCI To Appoint Expert Group To Consider Standards For Outcomes Measurement.

This article is from The Cancer Letter archive.

Vol. 26 No. 35 | September 29, 2000

Download PDF Visit The Full Archive

Related Articles

Bristol-Myers Nominations Open

August 10, 1979

Reduced-Fat Diet May Cut Risk Of Breast Cancer Recurrence.

December 22, 2006

FDA Encourages Study Of Gender Differences

August 6, 1993

FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin

April 5, 1985

NCI Advisory Group, Other Cancer Meetings For April, May

March 26, 1976

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

January 8, 1993